Avid Bioservices Inc (CDMO)

[biopharm]

Impressive and no MOS reached yet for those patient that were on Bavituximab + Docetaxel ....THEN went to other treatment ( wonder if it was Opdivo or Keytruda or....)

Ronin Capital Management may have made a big mistake not being able to get direct confirmation from PS Targeting experts on how valuable PS Targeting will be....

Looks like we may see Ronin Capital Management step up their strategy a bit now....and come to a conclusion quickly by ( some experts...?) that now PS Targeting is worth Billions more than what they even think Avid is worth.....

Will Ronin hedge group now place a $$$$$ tag on what they believe Peregrine is worth and pull off something that Peregrine may not expect?

....things become interesting AGAIN